Home/Filings/4/0001628280-23-026750
4//SEC Filing

O'Neill Kevin Michael 4

Accession 0001628280-23-026750

CIK 0001932393other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 4:05 PM ET

Size

11.2 KB

Accession

0001628280-23-026750

Insider Transaction Report

Form 4
Period: 2023-07-31
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2023-07-3113,2750 total
    Exercise: $40.40Exp: 2028-12-21Common Stock, par value $0.01 per share (13,275 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.01 per share

    2023-07-31$40.40/sh+13,275$536,31037,300 total
  • Sale

    Common Stock, par value $0.01 per share

    2023-07-31$76.55/sh2,334$178,66824,025 total
  • Sale

    Common Stock, par value $0.01 per share

    2023-07-31$77.46/sh13,275$1,028,28124,025 total
Footnotes (4)
  • [F1]The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $76.55 to $76.59, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
  • [F2]Includes sale of approximately 6,923 shares of GE HealthCare common stock to cover the exercise price of the stock options.
  • [F3]The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $77.45 to $77.55, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).
  • [F4]Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis, of which 100% are fully exercisable immediately.

Issuer

GE HealthCare Technologies Inc.

CIK 0001932393

Entity typeother

Related Parties

1
  • filerCIK 0001951605

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:05 PM ET
Size
11.2 KB